- Home
- MRNA vs MTSI Comparison
MRNA vs MTSI Comparison
Compare MRNA & MTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- MTSI
- Stock Information
- Founded
- MRNA 2010
- MTSI 1950
- Country
- MRNA United States
- MTSI United States
- Employees
- MRNA N/A
- MTSI N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- MTSI Semiconductors
- Sector
- MRNA Health Care
- MTSI Technology
- Exchange
- MRNA Nasdaq
- MTSI Nasdaq
- Market Cap
- MRNA 10.9B
- MTSI 9.2B
- IPO Year
- MRNA 2018
- MTSI 2012
- Fundamental
- Price
- MRNA $24.47
- MTSI $129.79
- Analyst Decision
- MRNA Hold
- MTSI Strong Buy
- Analyst Count
- MRNA 19
- MTSI 7
- Target Price
- MRNA $43.50
- MTSI $147.71
- AVG Volume (30 Days)
- MRNA 9.9M
- MTSI 737.2K
- Earning Date
- MRNA 11-06-2025
- MTSI 11-06-2025
- Dividend Yield
- MRNA N/A
- MTSI N/A
- EPS Growth
- MRNA N/A
- MTSI N/A
- EPS
- MRNA N/A
- MTSI N/A
- Revenue
- MRNA $3,078,000,000.00
- MTSI $906,798,000.00
- Revenue This Year
- MRNA N/A
- MTSI $35.60
- Revenue Next Year
- MRNA $10.17
- MTSI $13.41
- P/E Ratio
- MRNA N/A
- MTSI N/A
- Revenue Growth
- MRNA N/A
- MTSI 33.50
- 52 Week Low
- MRNA $23.15
- MTSI $84.00
- 52 Week High
- MRNA $79.96
- MTSI $152.50
- Technical
- Relative Strength Index (RSI)
- MRNA 38.50
- MTSI 50.10
- Support Level
- MRNA $23.78
- MTSI $129.17
- Resistance Level
- MRNA $25.48
- MTSI $134.22
- Average True Range (ATR)
- MRNA 1.09
- MTSI 3.82
- MACD
- MRNA 0.05
- MTSI 0.71
- Stochastic Oscillator
- MRNA 25.00
- MTSI 72.21
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.